A phase 3 trial of aspirin in colorectal cancer, run by Leiden University, active but no longer recruiting.
A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients is a phase 3, randomised interventional study registered as NCT02301286 by Leiden University, with a registry enrolment figure of 770 participants, started 2015-01 and due to reach its primary completion in 2027-12. Interventions recorded: Acetylsalicylic acid; Placebo Acetylsalicylic acid. Conditions listed: Colon Cancer; Adjuvant Therapy. Primary outcome: 5 year overall survival. Colorectal eligibility wording from the registry: "* Patients with rectal cancer (defined as tumour within 15 cm from the anal verge)". Sites: Netherlands. No results are recorded here; the registry entry is the source.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Aspirin, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.